Medicine valsartan + metformin in combined form for cardiovascular diseases.

摘要

"Medicine valsartan + metformin in combined form for cardiovascular diseases.Is the combination of two drugs used against cardiovascular diseases which are the main cause of death in the globalized world.There is significant correlation between weight gain and excess weight on the risk of cardiovascular diseases.Excess weight predisposes these diseases due to abnormalities in the metabolism of lipids, glucose, and blood pressure.Insulin resistance / hiperinsulinemia appears to be a risk factor independent of other associated risk factors, such as obesity, hyperlipidemia and hypertension.In both men and women.Insulin and growth factors similar to insulin stimulate activity.The smooth muscle cells and are involved in atherogenesis and restenosis even in the following that repair by coronary angioplasty.Other effects of insulin are related to the mechanisms that contribute to the development of hypertension with dyslipidemia.The utility model patent medicine 'valsartan + metformin in combined form for cardiovascular diseases, diminishes insulin resistance, blood pressure,The weight gain and improves the lipid profile of these patients, greatly reducing the likelihood of cardiovascular events and consequently the death of this nature.